Improved prediction of tablet properties with near-infrared spectroscopy by a fusion of scatter correction techniques.
Fusion
Multiblock
Multivariate
Pre-processing
Spectroscopy
Journal
Journal of pharmaceutical and biomedical analysis
ISSN: 1873-264X
Titre abrégé: J Pharm Biomed Anal
Pays: England
ID NLM: 8309336
Informations de publication
Date de publication:
05 Jan 2021
05 Jan 2021
Historique:
received:
22
08
2020
revised:
06
10
2020
accepted:
07
10
2020
pubmed:
26
10
2020
medline:
22
6
2021
entrez:
25
10
2020
Statut:
ppublish
Résumé
Near-infrared (NIR) spectra of pharmaceutical tablets get affected by light scattering phenomena, which mask the underlying peaks related to chemical components. Often the best performing scatter correction technique is selected from a pool of pre-selected techniques. However, the data corrected with different techniques may carry complementary information, hence, use of a single scatter correction technique is sub-optimal. In this study, the aim is to prove that NIR models related to pharmaceuticals can directly benefit from the fusion of complementary information extracted from multiple scatter correction techniques. To perform the fusion, sequential and parallel pre-processing fusion approaches were used. Two different open source NIR data sets were used for the demonstration where the assay uniformity and active ingredient (AI) content prediction was the aim. As a baseline, the fusion approach was compared to partial least-squares regression (PLSR) performed on standard normal variate (SNV) corrected data, which is a commonly used scatter correction technique. The results suggest that multiple scatter correction techniques extract complementary information and their complementary fusion is essential to obtain high-performance predictive models. In this study, the prediction error and bias were reduced by up to 15 % and 57 % respectively, compared to PLSR performed on SNV corrected data.
Identifiants
pubmed: 33099114
pii: S0731-7085(20)31570-3
doi: 10.1016/j.jpba.2020.113684
pii:
doi:
Substances chimiques
Tablets
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
113684Informations de copyright
Copyright © 2020 The Author(s). Published by Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.